Novogen (ASX:NRT) joint venture CanTx has chosen two US-based CMOs to manufacture batches of Cantrixil, the ovarian cancer drug candidate it aims to take to the clinic in mid-2015. [ + ]

The Judith Whitworth Fellowship for Gender Equality in Science is Australia's first major fellowship designed to help scientists build their careers after taking time off to look after their children. [ + ]

The 2014 Australian Research Council's (ARC) Future Fellowships will support 150 outstanding mid-career researchers. [ + ]

Research has uncovered a potential new approach to treating acute myeloid leukaemia. [ + ]

A new report shows that a reversal of the 2009 Employee Share Scheme (ESS) laws would potentially boost the Australian economy by more than $1.4 billion in the long term. [ + ]

The International Wound Management Research Collaboration has been formed to progress wound research. [ + ]

Postdoctoral, short- and long-term research fellowships are available to Australian researchers to work in Japan for 2015-2016. [ + ]

Minister for Education Christopher Pyne has announced $115 million in funding for 150 projects under the Australian Research Council's (ARC) Future Fellowships scheme. The scheme promotes research in areas of critical national importance by supporting outstanding mid-career researchers to conduct their work in Australia. [ + ]

ImpediMed (ASX:IPD) has named the Macquarie University Cancer Institute as the Australian site for a post-approval trial of L-Dex, its lymphodoema detection device. [ + ]

UK healthcare company Endomagnetics has reached an agreement with Aurora BioScience as its exclusive distributor for Australia and New Zealand. The appointment will provide breast cancer patients in the region with access to technology that optimally locates lymph nodes as part of the cancer staging procedure in sentinel lymph node biopsy (SLNB). [ + ]

A new guide for 'omics'-based tests, focusing on genomic testing, has been released for public consultation by the NHMRC. [ + ]

The US ITC has upheld an import ban on a device sold by Taiwan's APEX found to infringe on ResMed patents, even after a redesign. [ + ]

As part of changes to business support made in the May federal Budget, the Department of Industry's services will be accessed via a new one-stop web portal called the Single Business Service. [ + ]

The National Health and Medical Research Council (NHMRC) is seeking feedback on the document 'Principles for the translation of 'omics'-based tests from discovery to health care'. [ + ]

Calazada's (ASX:CZD) PolyNovo now has approval to market its NovoPore TNP dressing in the majority of its addressable market, after securing approvals in Europe. [ + ]